Overview

TD is a venture capital firm that specializes in the health care industry and has earned top-quartile rates of return on behalf of its investors. This performance is driven by disciplined due diligence and superior management of investments, coupled with a team approach to deal sourcing, structuring and management. Within health care, TD focuses on several segments:

• Biotechnology and life sciences
• Pharmaceuticals
• Health care services
• Medical devices

Through its national and regional presence, TD has established, funded and assisted in the growth of dozens of public and private companies with revenues ranging from zero into the billions of dollars. The firm fosters active cross-fertilization opportunities among its portfolio companies through its annual CEO conference, board membership opportunities for CEOs on other portfolio company boards, and the cultivation of relationships and new ideas among management teams.

Over the last 20 years, TD's team of accomplished business professionals has led many investments to successful outcomes, including Adams Respiratory Therapeutics (NasdaqGS: ARXT), PSS World Medical (NasdaqGM: PSSI), QuadraMed (AMEX: QD), and ViaCell (NasdaqGM: VIAC).

Providing Experience and Perspective

TD's principals encompass a broad range of business perspectives, while possessing specific skills needed by companies at different stages of growth.

• The firm has established, funded and assisted in the growth of dozens of public and private companies with revenues ranging from zero into the billions of dollars.
• TD's principals have extensive experience working with companies at the board level, providing continuing insight and direction.
• As directors, the firm's principals support portfolio companies with advice on strategy, financing, mergers, acquisitions, public offerings, and management team recruitment.
• TD fosters active cross-fertilization opportunities among its portfolio companies through its annual CEO conference, board memberships for CEOs on other portfolio company boards as appropriate, and the development of informal relationships and new ideas among management teams.